19
Participants
Start Date
March 3, 2020
Primary Completion Date
June 23, 2021
Study Completion Date
June 3, 2022
RES (Regenerative Epidermal Suspension) prepared using the RECELL® Autologous Cell Harvesting Device
Application of RES prepared using the RECELL® Autologous Cell Harvesting Device along with Telfa™ Clear primary and Xeroform™ secondary wound dressings.
Mepilex® Ag Wound Dressing
Application of Mepilex® Ag Wound Dressing
Conventional autografting (only when indicated)
When indicated, conventional autografting in accordance with Investigator's standard practice
Saint Christopher's Hospital for Children, Philadelphia
Evan Hayes Burn Center, Virginia Commonwealth University, Richmond
Wake Forest Baptist Medical Center, Winston-Salem
Medical University of South Carolina, Charleston
University of South Florida Tampa General Hospital, Tampa
University Medical Center New Orleans, New Orleans
Arizona Burn Center / Valleywise Health, Phoenix
University of Washington Regional Burn Center at Harborview Medical Center, Seattle
University of North Carolina, Chapel Hill
Lead Sponsor
Biomedical Advanced Research and Development Authority
FED
Avita Medical
INDUSTRY